Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.

Sarah M LofgrenMelanie R NicolAnanta S BangdiwalaKatelyn A PastickElizabeth C OkaforCaleb P SkipperMatthew F PullenNicole W EngenMahsa AbassiDarlisha A WilliamsAlanna A NasceneMargaret L AxelrodSylvain A LotherLauren J MacKenzieGlen DrobotNicole MartenMatthew P ChengRyan ZarychanskiIlan S SchwartzMichael SilvermanZain ChaglaLauren E KellyEmily G McDonaldTodd C LeeKathy H HullsiekDavid R BoulwareRadha Rajasingham

Published in: Open forum infectious diseases (2020)

NCT04308668 for postexposure prophylaxis and early treatment trials; NCT04328467 for pre-exposure prophylaxis trial.

Keyphrases

clinical trial
phase ii
coronavirus disease
study protocol
phase iii
sars cov
double blind
smoking cessation
placebo controlled